Algoritmo de testes sorológicos de triagem para infecção por HTLV-1/2 usado no Instituto Adolfo Lutz

Jacob, Fabrício; Santos-Fortuna, Elizabeth de los; Caterino-de-Araújo, Adele.
BEPA, Bol. epidemiol. paul. (Impr.) ; 5(49): 12-18, jan. 2008. ilus, tab
Artigo Português | Coleciona SUS (Brasil), SES-SP, SES SP - Centro de Documentação/CCD, SES-SP, SES SP - Acervo do Centro de Documentação/CCD, SES SP - Centro de Vigilância Epidemiológica, SES-SP | ID: biblio-944363

Documentos relacionados

  1. Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?
  2. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
  3. Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy.
  4. Interpretation of low reactivity in the Abbott Architect rHTLV I/II assay.
  5. Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T-cell leukaemia virus type-1 and type-2 infection in a London teaching hospital with a large solid organ transplant centre.
  6. Development of a nested real time PCR/high resolution melting assay for human T-cell lymphotropic viruses types 1 and 2 (HTLV-1 and 2) identification.
  7. Epidemiological and clinical aspects of human T-cell leukemia virus infection types 1 and 2: an introduction.
  8. Decline in human T-cell lymphotropic virus seroprevalence in blood donors from Minas Gerais, Brazil over a 12-year period (2006-2017).
  9. Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations.
  10. The prevalence of human T-cell leukemia virus in blood donors in China.